{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:55:14Z","timestamp":1781661314833,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82473958"],"award-info":[{"award-number":["No. 82473958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Semaphorins (SEMAs) comprise a diverse family of membrane-associated proteins whose dysregulation is implicated in various cancers, influencing tumor progression and immune responses. However, the role of SEMAs in colorectal cancer (CRC) remains underexplored. This study demonstrates that Semaphorin 6A (SEMA6A) is downregulated in CRC tissues, with low SEMA6A expression correlating with increased tumor aggressiveness and poor prognosis in CRC patients. Functional assays illustrate that SEMA6A overexpression exerts anti-tumor effects both in vitro and in vivo, while integrated RNA-seq and proteomic analyses identify ISG15 as a key downstream effector negatively regulated by SEMA6A. Mechanistically, SEMA6A inhibits the JAK-STAT3 pathway, leading to decreased ISG15 expression, which in turn abrogates the ISGylation-dependent stabilization of TGF-\u03b21 and promotes its degradation, as confirmed by molecular docking, co-immunoprecipitation, and cycloheximide chase assays. Consequently, in vitro co-culture assays and in vivo experiments reveal that SEMA6A overexpression in tumor cells enhances CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell cytotoxicity via blocking the ISG15\/TGF\u03b2 axis. Bioinformatics analyses indicate that patients with CRC exhibiting high SEMA6A and low ISG15 expression show improved responses to immunotherapy. Importantly, SEMA6A overexpression reshapes the tumor microenvironment, boosts anti-tumor immunity of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and inhibits immune evasion, thereby potentiating anti-PD-1 immunotherapy in vivo\n                    <jats:italic>.<\/jats:italic>\n                    Collectively, these findings highlight the potential of SEMA6A as a dual therapeutic strategy in CRC: inhibiting cancer progression while enhancing anti-tumor immunity by targeting the ISG15\/TGF-\u03b21 axis. Thus, SEMA6A represents both a prognostic indicator and a promising target to improve immunotherapy efficacy and enable personalized treatment strategies in CRC.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00493-6","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:21:59Z","timestamp":1781659319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEMA6A inhibits tumor progression and boosts anti-tumor immunity via blocking the ISG15\/TGF\u03b2 axis in colorectal cancer"],"prefix":"10.1186","volume":"7","author":[{"given":"Fang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-5961","authenticated-orcid":false,"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"22","key":"493_CR1","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1097\/cm9.0000000000001076","volume":"133","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang HY, Chen YK, Chen JJ, Song C, Gu J. Current status of surgical treatment of rectal cancer in China. Chin Med J. 2020;133(22):2703\u201311. https:\/\/doi.org\/10.1097\/cm9.0000000000001076.","journal-title":"Chin Med J"},{"issue":"3","key":"493_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"9719","key":"493_CR3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/s0140-6736(10)60353-4","volume":"375","author":"D Cunningham","year":"2010","unstructured":"Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375(9719):1030\u201347. https:\/\/doi.org\/10.1016\/s0140-6736(10)60353-4.","journal-title":"Lancet"},{"key":"493_CR4","doi-asserted-by":"publisher","unstructured":"Arneth B. Tumor Microenvironment. Medicina (Kaunas). 2019;56(1). https:\/\/doi.org\/10.3390\/medicina56010015.","DOI":"10.3390\/medicina56010015"},{"key":"493_CR5","doi-asserted-by":"publisher","unstructured":"Hirano T, Hirayama D, Wagatsuma K, Yamakawa T, Yokoyama Y, Nakase H. Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis. Int J Mol Sci. 2020;21(9). https:\/\/doi.org\/10.3390\/ijms21093062.","DOI":"10.3390\/ijms21093062"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2019.04.003","volume":"76","author":"D Ciardiello","year":"2019","unstructured":"Ciardiello D, Vitiello PP, Cardone C, Martini G, Troiani T, Martinelli E, et al. Immunotherapy of colorectal cancer: challenges for therapeutic efficacy. Cancer Treat Rev. 2019;76:22\u201332. https:\/\/doi.org\/10.1016\/j.ctrv.2019.04.003.","journal-title":"Cancer Treat Rev"},{"issue":"35","key":"493_CR7","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1200\/jco.2008.19.6147","volume":"27","author":"F Pag\u00e8s","year":"2009","unstructured":"Pag\u00e8s F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009;27(35):5944\u201351. https:\/\/doi.org\/10.1200\/jco.2008.19.6147.","journal-title":"J Clin Oncol"},{"key":"493_CR8","doi-asserted-by":"publisher","unstructured":"Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science (New York, N.Y.). 2013;342(6165):1432\u20133. https:\/\/doi.org\/10.1126\/science.342.6165.1432.","DOI":"10.1126\/science.342.6165.1432"},{"issue":"21","key":"493_CR9","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/jco.2010.28.3994","volume":"28","author":"KY Chung","year":"2010","unstructured":"Chung KY, Gore I, Fong L, Venook A, Beck SB, Dorazio P, et al. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J Clin Oncol. 2010;28(21):3485\u201390. https:\/\/doi.org\/10.1200\/jco.2010.28.3994.","journal-title":"J Clin Oncol"},{"issue":"26","key":"493_CR10","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455\u201365. https:\/\/doi.org\/10.1056\/NEJMoa1200694.","journal-title":"N Engl J Med"},{"issue":"26","key":"493_CR11","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, Mcdermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443\u201354. https:\/\/doi.org\/10.1056\/NEJMoa1200690.","journal-title":"N Engl J Med"},{"issue":"19","key":"493_CR12","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/jco.2009.26.7609","volume":"28","author":"JR Brahmer","year":"2010","unstructured":"Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28(19):3167\u201375. https:\/\/doi.org\/10.1200\/jco.2009.26.7609.","journal-title":"J Clin Oncol"},{"issue":"2","key":"493_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/1078-0432.Ccr-12-2625","volume":"19","author":"EJ Lipson","year":"2013","unstructured":"Lipson EJ, Sharfman WH, Drake CG, Wollner I, Taube JM, Anders RA, et al. Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin Cancer Res. 2013;19(2):462\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2625.","journal-title":"Clin Cancer Res"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"687319","DOI":"10.3389\/fmolb.2021.687319","volume":"8","author":"T Li","year":"2021","unstructured":"Li T, Yan Z, Wang W, Zhang R, Gan W, Lv S, et al. SEMA6B overexpression predicts poor prognosis and correlates with the tumor immunosuppressive microenvironment in colorectal cancer. Front Mol Biosci. 2021;8:687319. https:\/\/doi.org\/10.3389\/fmolb.2021.687319.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"493_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.chom.2020.03.007","volume":"27","author":"S Tian","year":"2020","unstructured":"Tian S, Liu Y, Wu H, Liu H, Zeng J, Choi MY, et al. Genome-wide CRISPR screen identifies Semaphorin 6A and 6B as receptors for Paeniclostridium sordellii toxin TcsL. Cell Host Microbe. 2020;27(5):782\u201392. https:\/\/doi.org\/10.1016\/j.chom.2020.03.007.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"493_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2007.01.028","volume":"53","author":"F Suto","year":"2007","unstructured":"Suto F, Tsuboi M, Kamiya H, Mizuno H, Kiyama Y, Komai S, et al. Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers. Neuron. 2007;53(4):535\u201347. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.028.","journal-title":"Neuron"},{"issue":"6","key":"493_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4161\/cbt.4.6.1733","volume":"4","author":"M Dhanabal","year":"2005","unstructured":"Dhanabal M, Wu F, Alvarez E, Mcqueeney KD, Jeffers M, Macdougall J, et al. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis. Cancer Biol Ther. 2005;4(6):659\u201368. https:\/\/doi.org\/10.4161\/cbt.4.6.1733.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"493_CR18","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.18632\/oncotarget.2995","volume":"6","author":"R Loria","year":"2015","unstructured":"Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, et al. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget. 2015;6(5):2779\u201393. https:\/\/doi.org\/10.18632\/oncotarget.2995.","journal-title":"Oncotarget"},{"issue":"2","key":"493_CR19","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.18632\/aging.202271","volume":"13","author":"R Tian","year":"2020","unstructured":"Tian R, Hu J, Ma X, Liang L, Guo S. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status. Aging. 2020;13(2):2418\u201335. https:\/\/doi.org\/10.18632\/aging.202271.","journal-title":"Aging"},{"issue":"5","key":"493_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.joim.2025.06.006","volume":"23","author":"B Jiang","year":"2025","unstructured":"Jiang B, Meng ZY, Hu YJ, Chen JJ, Zong L, Xu LY, et al. Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. J Integr Med. 2025;23(5):576\u201390. https:\/\/doi.org\/10.1016\/j.joim.2025.06.006.","journal-title":"J Integr Med"},{"issue":"1","key":"493_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000480321","volume":"43","author":"Q Chen","year":"2017","unstructured":"Chen Q, Yang W, Wang X, Li X, Qi S, Zhang Y, et al. TGF-\u03b21 induces EMT in bovine mammary epithelial cells through the TGF\u03b21\/Smad signaling pathway. Cell Physiol Biochem. 2017;43(1):82\u201393. https:\/\/doi.org\/10.1159\/000480321.","journal-title":"Cell Physiol Biochem"},{"key":"493_CR22","doi-asserted-by":"publisher","unstructured":"Zygulska AL, Pierzchalski P. Novel Diagnostic Biomarkers in Colorectal Cancer. Int J Mol Sci. 2022;23(2). https:\/\/doi.org\/10.3390\/ijms23020852.","DOI":"10.3390\/ijms23020852"},{"issue":"8","key":"493_CR23","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.147.8.2617","volume":"147","author":"M Recht","year":"1950","unstructured":"Recht M, Borden EC, Knight E Jr. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol. 1950;147(8):2617\u201323.","journal-title":"J Immunol"},{"issue":"5713","key":"493_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/279523a0","volume":"279","author":"PJ Farrell","year":"1979","unstructured":"Farrell PJ, Broeze RJ, Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature. 1979;279(5713):523\u20135. https:\/\/doi.org\/10.1038\/279523a0.","journal-title":"Nature"},{"issue":"2","key":"493_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41419-017-0138-9","volume":"9","author":"L Yoo","year":"2018","unstructured":"Yoo L, Yoon AR, Yun CO, Chung KC. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon. Cell Death Dis. 2018;9(2):97. https:\/\/doi.org\/10.1038\/s41419-017-0138-9.","journal-title":"Cell Death Dis"},{"issue":"2","key":"493_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2010.09.033","volume":"143","author":"B Skaug","year":"2010","unstructured":"Skaug B, Chen ZJ. Emerging role of ISG15 in antiviral immunity. Cell. 2010;143(2):187\u201390. https:\/\/doi.org\/10.1016\/j.cell.2010.09.033.","journal-title":"Cell"},{"issue":"12","key":"493_CR27","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1128\/jvi.01667-08","volume":"83","author":"TY Hsiang","year":"2009","unstructured":"Hsiang TY, Zhao C, Krug RM. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol. 2009;83(12):5971\u20137. https:\/\/doi.org\/10.1128\/jvi.01667-08.","journal-title":"J Virol"},{"issue":"5","key":"493_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbadis.2010.02.006","volume":"1802","author":"YJ Jeon","year":"2010","unstructured":"Jeon YJ, Yoo HM, Chung CH. ISG15 and immune diseases. Biochem Biophys Acta. 2010;1802(5):485\u201396. https:\/\/doi.org\/10.1016\/j.bbadis.2010.02.006.","journal-title":"Biochem Biophys Acta"},{"key":"493_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120464","author":"TL Yeung","year":"2018","unstructured":"Yeung TL, Tsai CC, Leung CS, Au Yeung CL, Thompson MS, Lu KH, et al. ISG15 promotes ERK1 ISGylation, CD8+ T cell activation and suppresses ovarian cancer progression. Cancers. 2018. https:\/\/doi.org\/10.3390\/cancers10120464.","journal-title":"Cancers"},{"issue":"5","key":"493_CR30","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1002\/jcp.27347","volume":"234","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ding Q, Lu YC, Cao SY, Liu QX, Zhang L. Interferon-stimulated gene 15 enters posttranslational modifications of p53. J Cell Physiol. 2019;234(5):5507\u201318. https:\/\/doi.org\/10.1002\/jcp.27347.","journal-title":"J Cell Physiol"},{"issue":"13","key":"493_CR31","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.18632\/oncotarget.7626","volume":"7","author":"RH Chen","year":"2016","unstructured":"Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, et al. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget. 2016;7(13):16910\u201322. https:\/\/doi.org\/10.18632\/oncotarget.7626.","journal-title":"Oncotarget"},{"issue":"6","key":"493_CR32","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/onc.2012.633","volume":"33","author":"J Burks","year":"2014","unstructured":"Burks J, Reed RE, Desai SD. ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene. 2014;33(6):794\u2013803. https:\/\/doi.org\/10.1038\/onc.2012.633.","journal-title":"Oncogene"},{"issue":"9","key":"493_CR33","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","volume":"21","author":"M Ochoa De Olza","year":"2020","unstructured":"Ochoa De Olza M, Navarro Rodrigo B, Zimmermann S, Coukos G. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol. 2020;21(9):e419\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(20)30234-5.","journal-title":"Lancet Oncol"},{"key":"493_CR34","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.ctrv.2021.102227","volume":"101","author":"C Gerard","year":"2021","unstructured":"Gerard C, Delyon J, Wicky A, Homicsko K, Cuendet MA. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat Rev. 2021;101:102227.","journal-title":"Cancer Treat Rev"},{"key":"493_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, et al. Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol. 2019;10:168. https:\/\/doi.org\/10.3389\/fimmu.2019.00168.","journal-title":"Front Immunol"},{"issue":"2","key":"493_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41590-022-01384-y","volume":"24","author":"AA Saadey","year":"2023","unstructured":"Saadey AA, Yousif A, Osborne N, Shahinfar R, Chen Y-L, Laster B, et al. Rebalancing TGF\u03b21\/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy. Nat Immunol. 2023;24(2):280\u201394. https:\/\/doi.org\/10.1038\/s41590-022-01384-y.","journal-title":"Nat Immunol"},{"key":"493_CR37","doi-asserted-by":"publisher","unstructured":"Goytain A, Ng T. NanoString nCounter Technology: High-Throughput RNA Validation. Met Mol Biol. 2020;2079(125\u2013139. https:\/\/doi.org\/10.1007\/978-1-4939-9904-0_10.","DOI":"10.1007\/978-1-4939-9904-0_10"},{"issue":"3","key":"493_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu Z. Complex heatmap visualization. Imeta. 2022;1(3):e43. https:\/\/doi.org\/10.1002\/imt2.43.","journal-title":"Imeta"},{"issue":"7","key":"493_CR39","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00493-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:22:00Z","timestamp":1781659320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00493-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was approved by the Research Ethics Committee of The Affiliated Hospital of Qingdao University (QDU-HEC-2023177), and written informed consent was obtained from all patients. Animal experiments complied with EU Directive 2010\/63\/EU and were approved by the Institutional Animal Care and Use Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (IMM-N-25-0216).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants included in the study. No identifiable personal information is included, and all data have been anonymized to ensure confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}